Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Jun;118(4):865–870. doi: 10.1111/j.1476-5381.1996.tb15479.x

Effects of beta-adrenoceptor antagonists on Ca(2+)-overload induced by lysophosphatidylcholine in rat isolated cardiomyocytes.

M Chen 1, H Hashizume 1, Y Abiko 1
PMCID: PMC1909535  PMID: 8799555

Abstract

1. The effects of beta-adrenoceptor antagonists including (-)- and (+)-propranolol, (-)- and (+)-penbutolol, timolol, pindolol, atenolol, acebutolol and practolol on the Ca(2+)-overload induced by lysophosphatidylcholine (LPC) were examined in isolated cardiomyocytes of the rat. 2. Fura-2 was used for measurement of the intracellular calcium concentration ([Ca2+]i). LPC (15 microM) produced a rapid increase in [Ca2+]i from 72 +/- 5 to 3042 +/- 431 nM which coincided with a decrease in the percentage of rod-shaped cells from 69 +/- 2 to 5 +/- 2%. 3. Preincubation with (-)-propranolol (20 microM), (+)-propranolol (50 microM), or (-)- or (+)-penbutolol (20 microM), the lipophilicity of which is higher than other beta-adrenoceptor antagonists, significantly inhibited both the increase in [Ca2+]i and the cell-shape change induced by 15 microM LPC. The inhibitory effects of the four drugs on the LPC-induced increase in [Ca2+]i and cell-shape change were concentration-dependent. The IC50S of (-)-propranolol, (+)-propranolol, (-)- and (+)-penbutolol for the increase in [Ca2+]i were 1.28, 10.50, 0.67 and 0.76 microM, respectively. 4. Pretreatment with pindolol, timolol, acebutolol, practolol, atenolol or lignocaine did not inhibit the increase in [Ca2+]i and the morphological change induced by LPC. 5. LPC markedly increased the release of creatine phosphokinase from 9 +/- 1 to 45 +/- 2% which could be significantly reduced by (-)- or (+)-propranolol but not by acebutolol or timolol. 6. The protective effects of (-)- and (+)-propranolol, (-)- and (+)-penbutolol against the Ca(2+)-overload induced by LPC were not associated with the beta-adrenoceptor antagonistic action, but probably with an unknown action which is related to the preservation of membrane integrity. Further studies are necessary to clarify the exact mechanisms of the protective action of these beta-adrenoceptor antagonists against the Ca(2+)-overload induced by LPC.

Full text

PDF
865

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Colquhoun D., Neher E., Reuter H., Stevens C. F. Inward current channels activated by intracellular Ca in cultured cardiac cells. Nature. 1981 Dec 24;294(5843):752–754. doi: 10.1038/294752a0. [DOI] [PubMed] [Google Scholar]
  2. Corr P. B., Gross R. W., Sobel B. E. Amphipathic metabolites and membrane dysfunction in ischemic myocardium. Circ Res. 1984 Aug;55(2):135–154. doi: 10.1161/01.res.55.2.135. [DOI] [PubMed] [Google Scholar]
  3. Corr P. B., Snyder D. W., Lee B. I., Gross R. W., Keim C. R., Sobel B. E. Pathophysiological concentrations of lysophosphatides and the slow response. Am J Physiol. 1982 Aug;243(2):H187–H195. doi: 10.1152/ajpheart.1982.243.2.H187. [DOI] [PubMed] [Google Scholar]
  4. DaTorre S. D., Creer M. H., Pogwizd S. M., Corr P. B. Amphipathic lipid metabolites and their relation to arrhythmogenesis in the ischemic heart. J Mol Cell Cardiol. 1991 Feb;23 (Suppl 1):11–22. doi: 10.1016/0022-2828(91)90019-i. [DOI] [PubMed] [Google Scholar]
  5. Das D. K., Engelman R. M., Rousou J. A., Breyer R. H., Otani H., Lemeshow S. Role of membrane phospholipids in myocardial injury induced by ischemia and reperfusion. Am J Physiol. 1986 Jul;251(1 Pt 2):H71–H79. doi: 10.1152/ajpheart.1986.251.1.H71. [DOI] [PubMed] [Google Scholar]
  6. Dohadwalla A. N., Freedberg A. S., Vaughan Williams E. M. The relevance of beta-receptor blockade to ouabain-induced cardiac arrhythmias. Br J Pharmacol. 1969 Jun;36(2):257–267. doi: 10.1111/j.1476-5381.1969.tb09503.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fujioka H., Yoshihara S., Tanaka T., Fukumoto T., Kuroiwa A., Tanonaka K., Hayashi M., Takeo S. Enhancement of post-hypoxic contractile and metabolic recovery of perfused rat hearts by dl-propranolol: possible involvement of non-beta-receptor mediated activity. J Mol Cell Cardiol. 1991 Aug;23(8):949–962. doi: 10.1016/0022-2828(91)90137-b. [DOI] [PubMed] [Google Scholar]
  8. Giudicelli J. F., Schmitt H., Boissier J. R. Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole A/Giudicelli JF, Schmitt H, Boissier JR: Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB 46), a new potent beta adrenergic blocking drug. J Pharmacol Exp Ther. 1969 Jul;168(1):116–126. [PubMed] [Google Scholar]
  9. Grynkiewicz G., Poenie M., Tsien R. Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985 Mar 25;260(6):3440–3450. [PubMed] [Google Scholar]
  10. Hashizume H., Akiyama K., Abiko Y. Effects of antiischemic drugs on veratridine-induced hypercontracture in rat cardiac myocytes. Eur J Pharmacol. 1994 Dec 12;271(1):1–8. doi: 10.1016/0014-2999(94)90257-7. [DOI] [PubMed] [Google Scholar]
  11. Hoque A. N., Hoque N., Hashizume H., Abiko Y. A study on dilazep: II. Dilazep attenuates lysophosphatidylcholine-induced mechanical and metabolic derangements in the isolated, working rat heart. Jpn J Pharmacol. 1995 Mar;67(3):233–241. doi: 10.1254/jjp.67.233. [DOI] [PubMed] [Google Scholar]
  12. Hoque A. N., Nasa Y., Abiko Y. Cardioprotective effect of d-propranolol in ischemic-reperfused isolated rat hearts. Eur J Pharmacol. 1993 May 19;236(2):269–277. doi: 10.1016/0014-2999(93)90598-c. [DOI] [PubMed] [Google Scholar]
  13. Kinnaird A. A., Choy P. C., Man R. Y. Lysophosphatidylcholine accumulation in the ischemic canine heart. Lipids. 1988 Jan;23(1):32–35. doi: 10.1007/BF02535301. [DOI] [PubMed] [Google Scholar]
  14. Kodama I., Shimizu T., Iwamura N., Hirata Y., Toyama J., Yamada K. Effects of l-penbutolol (Hoe 893d) on the transmembrane potentials of canine purkinje fibers and ventricular muscle fibers. Arch Int Pharmacodyn Ther. 1978 Feb;231(2):232–242. [PubMed] [Google Scholar]
  15. Kramer J. H., Mak I. T., Freedman A. M., Weglicki W. B. Propranolol reduces anoxia/reoxygenation-mediated injury of adult myocytes through an anti-radical mechanism. J Mol Cell Cardiol. 1991 Nov;23(11):1231–1244. doi: 10.1016/0022-2828(91)90081-v. [DOI] [PubMed] [Google Scholar]
  16. Liu E., Goldhaber J. I., Weiss J. N. Effects of lysophosphatidylcholine on electrophysiological properties and excitation-contraction coupling in isolated guinea pig ventricular myocytes. J Clin Invest. 1991 Dec;88(6):1819–1832. doi: 10.1172/JCI115503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Liu X. K., Engelman R. M., Agrawal H. R., Das D. K. Preservation of membrane phospholipids by propranolol, pindolol, and metoprolol: a novel mechanism of action of beta-blockers. J Mol Cell Cardiol. 1991 Oct;23(10):1091–1100. doi: 10.1016/0022-2828(91)90199-v. [DOI] [PubMed] [Google Scholar]
  18. Lu H. R., Vandeplassche G., Wouters L., Flameng W., Borgers M. Effects of beta-adrenoceptor antagonists on cardiac function in ischemic-reperfused myocardium of the isolated working rabbit heart. Eur J Pharmacol. 1990 Aug 2;184(1):65–74. doi: 10.1016/0014-2999(90)90667-u. [DOI] [PubMed] [Google Scholar]
  19. Mak I. T., Weglicki W. B. Protection by beta-blocking agents against free radical-mediated sarcolemmal lipid peroxidation. Circ Res. 1988 Jul;63(1):262–266. doi: 10.1161/01.res.63.1.262. [DOI] [PubMed] [Google Scholar]
  20. Man R. Y., Kinnaird A. A., Bihler I., Choy P. C. The association of lysophosphatidylcholine with isolated cardiac myocytes. Lipids. 1990 Aug;25(8):450–454. doi: 10.1007/BF02538087. [DOI] [PubMed] [Google Scholar]
  21. Michiels M., Hendriks R., Knaeps F., Woestenborghs R., Heykants J. Absorption and tissue distribution of flunarizine in rats, pigs and dogs. Arzneimittelforschung. 1983;33(8):1135–1142. [PubMed] [Google Scholar]
  22. Murphy E., Jacob R., Lieberman M. Cytosolic free calcium in chick heart cells. Its role in cell injury. J Mol Cell Cardiol. 1985 Mar;17(3):221–231. doi: 10.1016/s0022-2828(85)80005-5. [DOI] [PubMed] [Google Scholar]
  23. Piper H. M., Probst I., Schwartz P., Hütter F. J., Spieckermann P. G. Culturing of calcium stable adult cardiac myocytes. J Mol Cell Cardiol. 1982 Jul;14(7):397–412. doi: 10.1016/0022-2828(82)90171-7. [DOI] [PubMed] [Google Scholar]
  24. Sada H., Ban T. Effects of acebutolol and other structurally related beta adrenergic blockers on transmembrane action potential in guinea-pig papillary muscles. J Pharmacol Exp Ther. 1980 Nov;215(2):507–514. [PubMed] [Google Scholar]
  25. Sedlis S. P., Corr P. B., Sobel B. E., Ahumada G. G. Lysophosphatidyl choline potentiates Ca2+ accumulation in rat cardiac myocytes. Am J Physiol. 1983 Jan;244(1):H32–H38. doi: 10.1152/ajpheart.1983.244.1.H32. [DOI] [PubMed] [Google Scholar]
  26. Takeo S., Yamada H., Tanonaka K., Hayashi M., Sunagawa N. Possible involvement of membrane-stabilizing action in beneficial effect of beta adrenoceptor blocking agents on hypoxic and posthypoxic myocardium. J Pharmacol Exp Ther. 1990 Sep;254(3):847–856. [PubMed] [Google Scholar]
  27. Ver Donck L., Verellen G., Geerts H., Borgers M. Lysophosphatidylcholine-induced Ca(2+)-overload in isolated cardiomyocytes and effect of cytoprotective drugs. J Mol Cell Cardiol. 1992 Sep;24(9):977–988. doi: 10.1016/0022-2828(92)91864-2. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES